China Jianyin Investment and Tamar Alliance Partners Fund I’s Acquisition of a majority share of Nature’s Care

Clifford Chance and Norton Rose Fulbright advised on the deal

China Jianyin Investment Limited, JIC Huawen Investment Limited and Tamar Alliance Capital (the Consortium) announced the acquisition of a majority stake in Australia’s leading vitamins and supplements business, Nature’s Care. Nature’s Care owns leading brands such as Healthy Care, Nature’s Care Pro Series, Royal, Vitamore, VitAustralia, Leimei and Mei Mei Organic. The transaction is subject to regulatory approvals and is expected to close in the second half of 2018.

Nature’s Care manufactures in Sydney, Australia, and is one of the largest vitamins and supplements companies in Australia.

JIC is an integrated investment group which, at the end of 2017, managed over US$85 billion in assets.

Tamar is a private equity fund focused on investments in the consumer and healthcare sectors in China and Southeast Asia. The fund is owned by CITIC Pacific Limited and Dah Chong Kong Holdings Limited.

A joint team from Clifford Chance’s Beijing and Sydney offices advised the Consortium on the acquisition and the related acquisition financing. The M&A team was jointly led by China co-managing partner Terence Foo (Picture), Sydney partner Lance Sacks, Beijing counsel Hong Zhang and Sydney counsel Amelia Horvath, who were supported by senior associate Janet Jiang and associate Tom Wong from Beijing and Sydney associates Ned Purcell and James Kwong. Acquisition financing was led by Australia managing partner Richard Gordon in Sydney and partner Timothy Democratis in Beijing, supported by counsel Alastair Gourlay and associate Victor Greenstreet in Sydney. Antitrust and regulatory advice was provided by Beijing counsel Bai Yong and associate Zibo Liu.

Norton Rose Fulbright has advised the Wu family, founders of Nature’s Care with a team including Richard G Lewis, Matthew Nelson, William Nicolson, Ian Giles and Sun Hong.

Involved fees earner: Richard Lewis – Norton Rose Fulbright; Matthew Nelson – Norton Rose Fulbright; William Nicolson – Norton Rose Fulbright; Sun Hong – Norton Rose Fulbright; Ian Giles – Norton Rose Fulbright; Terence Foo – Clifford Chance; Lance Sacks – Clifford Chance; Hong Zhang – Clifford Chance; Amelia Horvath – Clifford Chance; Janet Jiang – Clifford Chance; Tom Wong – Clifford Chance; Ned Purcell – Clifford Chance; James Kwong – Clifford Chance; Richard Gordon – Clifford Chance; Timothy Democratis – Clifford Chance; Alastair Gourlay – Clifford Chance; Victor Greenstreet – Clifford Chance; Bai Yong – Clifford Chance; Zibo Liu – Clifford Chance;

Law Firms: Norton Rose Fulbright; Clifford Chance;

Clients: China Jianyin Investment Ltd.; JIC Huawen Investment Ltd; Tamar Alliance Capital; Jack Wu; Alex Wu; Jina Wu;


Author: Michael Patrini